<DOC>
	<DOCNO>NCT00455858</DOCNO>
	<brief_summary>This trial conduct Asia . This trial aim evaluate glycaemic control , measure glycosylated haemoglobin ( Hb1Ac ) , daily insulin detemir add-on oral antidiabetic drug ( OAD ) subject type 2 diabetes mellitus Korea .</brief_summary>
	<brief_title>Evaluation Glycaemic Control With Insulin Detemir add-on Current Oral Anti-diabetic Drug Treatment Subjects With Type 2 Diabetes Korea</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Type 2 diabetes ( diagnosed 12 month ago ) HbA1c great 7.0 less 12.0 % screen Currently OAD 3 month ago BMI ( Body Mass Index ) less 35kg/m2 Previous treatment insulin 7 day within last 3 month Uncontrolled treated/untreated hypertension ( systolic blood pressure great 180mmHg and/or diastolic blood pressure le 110mmHg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>